Return to homepagePandemic Pact

THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTA

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N91019D00024-P00003-759102000003-52

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Known Financial Commitments (USD)

    $484,000

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    LEONARD FREEDMAN

  • Research Location

    United States of America

  • Lead Research Institution

    LEIDOS BIOMEDICAL RESEARCH, INC.

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Advanced BioScience Laboratories, Inc. (ABL) is a global contract manufacturing organization with experience in biologics R&D, scale-up, and production following current Good Manufacturing Practices (cGMP). ABL partners with our clients to support GMP manufacturing needs. Dr. Wlodawer, Chief of the Macromolecular Crystallography Laboratory with the NCI-Frederick is working on a project, Chimeric ACE2 Peptide Ligand for Diagnostic Assays of SARS-CoV-2, under the Intramural Targeted Anti-Covid19 (ITAC) Program, which provides supplementary support for COVID-19 research activities for intramural investigators